A collection of 28 hemp non-profit organizations issued the letter, urging the committee to expedite an FDA hearing regarding regulations to the hemp industry.
Representatives from the hemp industry recently joined forces to issue a letter to leaders of the House of Energy and Commerce Committee, urging the committee to expedite a hearing on the Food and Drug Administration’s (FDA) regulation of the hemp market, including products such as CBD.
Among contributors to the letter were 28 non-profit organizations, representing every element of the hemp food chain and every region in the U.S., as well as four leading national dietary supplement organizations.
“In the more than five years since the legalization of hemp through the 2018 Farm Bill, in spite of a designated annual appropriation, the FDA has taken no meaningful steps toward the regulation of hemp — whether it be animal feed or extracts for human consumption like CBD,” the letter read.
The group also stated that the “repercussions of FDA inaction extend beyond consumer confusion,” noting that U.S. farmers have suffered economically, with commodity prices dropping by more than 90%.
Read more
Hemp Industry Representatives Issue Letter to House Energy and Commerce Committee
